E-LIB Suche - Ergebnisse für: Patat, A.

1

AL-335, a Once-Daily Pangenotypic Nucleotide HCV Polymerase..:

Berliba, E. ; Tsertsvadze, T. ; Ghicavii, N....
Journal of Hepatology. 64 (2016) 2 - p. S404-S405 , 2016

Link: https://doi.org/10.1016/..

2

866 ALS-2200, A NOVEL ONCE-DAILY NUCLEOTIDE HCV POLYMERASE ..:

Marcellin, P. ; Popa, S. ; Streinu-Cercel, A....
Journal of Hepatology. 58 (2013) - p. S355 , 2013

Link: https://doi.org/10.1016/..

3

The Effect of Safinamide, a Novel Drug for Parkinson's Dise..:

Marquet, A ; Kupas, K ; Johne, A...
Clinical Pharmacology & Therapeutics. , 2012

Link: https://doi.org/10.1038/..

4

P.1.g.021 Comparison of AChE inhibition/5-HT1A blockade in ..:

Parks, V. ; Patat, A. ; Raje, S...
European Neuropsychopharmacology. 20 (2010) - p. S320 , 2010

Link: https://doi.org/10.1016/..

5

85 ANTIVIRAL ACTIVITY AND SAFETY OF ITMN-191 IN COMBINATION..:

Forestier, N. ; Larrey, D. ; Marcellin, P....
Journal of Hepatology. 50 (2009) - p. S35 , 2009

Link: https://doi.org/10.1016/..

6

A Positron Emission Tomography Study to Assess Binding of L..:

Raje, S ; Patat, A A ; Parks, V...
Clinical Pharmacology & Therapeutics. 83 (2007) 1 - p. 86-96 , 2007

Link: https://doi.org/10.1038/..

7

PIII-39Safety, tolerability and pharmacokinetics (PK) of mu..:

PARKS, V ; RAJE, S ; PATAT, A...
Clinical Pharmacology & Therapeutics. 79 (2006) 2 - p. P68-P68 , 2006

Link: https://doi.org/10.1016/..

8

PI-34Use of positron emission tomography (PET) to assist in..:

PATAT, A ; RAJE, S ; LANGSTROM, B...
Clinical Pharmacology & Therapeutics. 79 (2006) 2 - p. P16-P16 , 2006

Link: https://doi.org/10.1016/..

9

PI-73Effects of chronic hepatic impairment on the pharmacok..:

BAIRDBELLAIRE, S ; PATAT, A ; FAUCHOUX, N...
Clinical Pharmacology & Therapeutics. 79 (2006) 2 - p. P26-P26 , 2006

Link: https://doi.org/10.1016/..

10

PII-33Relative bioavailability of three modified release fo..:

RAJE, S ; PARKS, V ; PLOTKA, A..
Clinical Pharmacology & Therapeutics. 79 (2006) 2 - p. P45-P45 , 2006

Link: https://doi.org/10.1016/..

11

PI-71Absence of drug interaction between rotigaptide (ZP123..:

UDATA, C ; PARKS, V ; PATAT, A..
Clinical Pharmacology & Therapeutics. 79 (2006) 2 - p. P25-P25 , 2006

Link: https://doi.org/10.1016/..

12

Safety, pharmacokinetics (Pk) and pharmacodynamics (PD) of ..:

PARKS, V ; PATAT, A ; BEHRLE, J..
Clinical Pharmacology & Therapeutics. 77 (2005) 2 - p. P44-P44 , 2005

Link: https://doi.org/10.1016/..

13

An open-label, randomized, crossover study of the relative ..:

NICHOLS, A ; PATAT, A ; BAIRDBELLAIRE, S..
Clinical Pharmacology & Therapeutics. 77 (2005) 2 - p. P86-P86 , 2005

Link: https://doi.org/10.1016/..

14

Safety, pharmacokinetics (PK) and pharmacodynamics (PD) of ..:

PARKS, V ; PATAT, A ; BEHRLE, J..
Clinical Pharmacology & Therapeutics. 77 (2005) 2 - p. P28-P28 , 2005

Link: https://doi.org/10.1016/..

15

Age-gender study of SRA-333, a novel 5-HT antagonist:

PATAT, A ; PARKS, V ; RAJE, S..
Clinical Pharmacology & Therapeutics. 77 (2005) 2 - p. P29-P29 , 2005

Link: https://doi.org/10.1016/..